GLP1R and type 2 diabetes mellitus: Metformin, a cornerstone in the treatment of patients with T2D, has been reported to alter circulating GLP-1 levels [7]–[9], in addition to its effects on hepatic glucose output and peripheral insulin sensitivity [10], [11].